跳转至内容
Merck
CN

B7149

Sigma-Aldrich

苄噻嗪

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C15H14ClN3O4S3
CAS号:
分子量:
431.94
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
NACRES:
NA.22

表单

solid

质量水平

SMILES字符串

NS(=O)(=O)c1cc2c(NC(CSCc3ccccc3)=NS2(=O)=O)cc1Cl

InChI

1S/C15H14ClN3O4S3/c16-11-6-12-14(7-13(11)25(17,20)21)26(22,23)19-15(18-12)9-24-8-10-4-2-1-3-5-10/h1-7H,8-9H2,(H,18,19)(H2,17,20,21)

InChI key

NDTSRXAMMQDVSW-UHFFFAOYSA-N

基因信息

human ... SLC12A3(6559)

正在寻找类似产品? 访问 产品对比指南

象形图

Health hazard

警示用语:

Danger

危险声明

预防措施声明

危险分类

Resp. Sens. 1 - Skin Sens. 1

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Thiazides XIII: Dissolution testing: a bioavailability predictor for benzthiazide tablets.
V P Shah et al.
Biopharmaceutics & drug disposition, 3(3), 283-285 (1982-07-01)
Laurie De Wilde et al.
Journal of chromatography. A, 1579, 31-40 (2018-11-16)
Diuretics can be misused to force diuresis to achieve weight loss or to mask the intake of a prohibited substance and are therefore prohibited by the World Anti-Doping Agency (WADA). For similar reasons other masking agents (vaptans, probenecid, etc.) are
J P Huang et al.
Journal of analytical toxicology, 23(5), 337-342 (1999-09-17)
This study describes a matrix-assisted laser-desorption-ionization (MALDI) mass spectrometry for rapid screening of 12 diuretics in spiked urine. C60 is used as the matrix for MALDI. Diuretics are directly analyzed by C60-MALDI without previous derivatization. The fact that most diuretic
L R Berkowitz
The American journal of physiology, 258(4 Pt 1), C622-C629 (1990-04-01)
The thioalkylating agent N-ethylmaleimide (NEM) causes ouabain-insensitive K loss from human red blood cells. This K loss is inhibited when intracellular Cl is replaced by another permeant anion or when loop diuretics are placed in the incubation medium after NEM
Hee Sook Lee et al.
BMC systems biology, 6, 80-80 (2012-07-04)
The process of drug discovery and development is time-consuming and costly, and the probability of success is low. Therefore, there is rising interest in repositioning existing drugs for new medical indications. When successful, this process reduces the risk of failure

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门